LDLR and metabolic syndrome: Genotype–phenotype correlations revealed that LDLR variants were associated with more severe biochemical profiles and a higher frequency of clinical manifestations, including xanthelasma and CVD, reinforcing its central pathogenic role in monogenic dyslipidemias [75].